Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 6,034 | 4,251 | 3,570 | 1,712 | 1,857 |
| Cost of Goods | 1,285 | 1,066 | 1,755 | 955 | 839 |
| Gross Profit | 4,749 | 3,185 | 1,815 | 757 | 1,018 |
| Operating Expenses | 29,453 | 32,180 | 39,988 | 45,081 | 42,999 |
| Operating Income | -24,419 | -28,929 | -37,418 | -43,369 | -41,142 |
| Other Income | -101,541 | -2,956 | -14,130 | -30,692 | 7,728 |
| Pre-tax Income | -125,960 | -31,885 | -51,548 | -74,061 | -33,414 |
| Income Tax | 20 | -3 | 4 | 0 | 12 |
| Net Income Continuous | -125,980 | -31,882 | -51,552 | -74,061 | -33,426 |
| Net Income | $-125,980 | $-31,888 | $-51,554 | $-74,061 | $-33,426 |
| EPS Basic Total Ops | -580.48 | -360.25 | -495.00 | -900.00 | -501.25 |
| EPS Basic Continuous Ops | -580.48 | -359.27 | -480.73 | -900.16 | -500.71 |
| EPS Diluted Total Ops | -580.48 | -360.25 | -495.00 | -900.00 | -501.25 |
| EPS Diluted Continuous Ops | -580.48 | -359.27 | -480.73 | -900.16 | -500.71 |
| EBITDA(a) | $-24,169 | $-28,664 | $-37,133 | $-43,101 | $-40,867 |